Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

940 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
Reims HM, Oparil S, Kjeldsen SE, Devereux RB, Julius S, Brady WE, Fyhrquist F, Ibsen H, Lindholm LH, Omvik P, Wedel H, Beevers G, de Faire U, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Dahlöf B; LIFE Study Group. Reims HM, et al. Among authors: oparil s. Blood Press. 2004;13(6):376-84. doi: 10.1080/08037050410016483. Blood Press. 2004. PMID: 15771223 Clinical Trial.
New ESH/ESC guidelines signal progress in hypertension management.
Hedner T T, Narkiewicz K, Kjeldsen SE, Oparil S; European Society of Hypertension; European Society of Cardiology. Hedner T T, et al. Among authors: oparil s. Blood Press. 2007;16(3):132-4. doi: 10.1080/08037050701550746. Blood Press. 2007. PMID: 17846924 No abstract available.
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
Fyhrquist F, Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Hille DA, Lyle PA, Edelman JM, Snapinn SM, Wedel H; LIFE Study Group. Fyhrquist F, et al. Among authors: oparil s. Hypertension. 2005 Apr;45(4):580-5. doi: 10.1161/01.HYP.0000161186.55933.6b. Hypertension. 2005. PMID: 15790960
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B. Devereux RB, et al. Among authors: oparil s. Curr Med Res Opin. 2007 Feb;23(2):259-70. doi: 10.1185/030079906X162854. Curr Med Res Opin. 2007. PMID: 17288679 Clinical Trial.
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Dahlöf B, et al. Among authors: oparil s. Hypertension. 1998 Dec;32(6):989-97. doi: 10.1161/01.hyp.32.6.989. Hypertension. 1998. PMID: 9856962 Clinical Trial.
940 results